Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results
HONG KONG, Nov. 18, 2020 /PRNewswire/ --Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services,today announced that it plans to release unaudited financial results for the secondquarter and first half of fiscal year 2021 on Tuesday, November 24, 2020, after the U.S. market close.
- HONG KONG, Nov. 18, 2020 /PRNewswire/ --Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services,today announced that it plans to release unaudited financial results for the secondquarter and first half of fiscal year 2021 on Tuesday, November 24, 2020, after the U.S. market close.
- ET on Wednesday, November 25, 2020 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session.
- Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses.
- Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.